MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ActivePassive International Equity ETF (NY:APIE)

37.13 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Apr 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 37.13
Bid (Size) 14.86 (200)
Ask (Size) 59.40 (200)
Prev. Close 37.13
Today's Range 37.13 - 37.13
52wk Range 26.18 - 39.06
Shares Outstanding 257,750
Dividend Yield 3.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk To Launch Ozempic Pills Following Flat Growth In Diabetes Segment In 2025 ↗
The Ozempic pill will be launched in Q2 2026 and be available in doses 1.5 mg, 4 mg, and 9 mg. 
Via Stocktwits
News headline image
Novo Nordisk Shares Tumble On Q4 Miss, Weak Sales Forecast And Competition Concerns ↗
The drugmaker now expects fiscal 2026 adjusted sales down 5% to 13%. 
Via Stocktwits

Performance

YTD
+2.8%
+2.8%
1 Month
+2.5%
+2.5%
3 Month
+2.1%
+2.1%
6 Month
+2.4%
+2.4%
1 Year
+40.5%
+40.5%

More News

Read More
News headline image
Novo Nordisk Inks Deal With Canada’s Aspect Biosystems To Find More Diabetes Meds Besides Ozempic ↗
Via Stocktwits
Ryanair Turns Up Heat After Calling Press Briefing On Musk, Launches ‘Great Idiots Sale’ Taking Aim At SpaceX Owner ↗
Via Stocktwits
News headline image
NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment ↗
Via Stocktwits
Ryanair Pulls Plug On Prime Membership Offering After Trial Proves Too Costly ↗
Via Stocktwits
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study ↗
Via Stocktwits
Why Did BioNTech Stock Surge 10% Pre-Market Today? ↗
Via Stocktwits
News headline image
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies ↗
Via Stocktwits
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More ↗
Via Stocktwits
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report ↗
Via Stocktwits
News headline image
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants ↗
Via Stocktwits
Topics Death Government
News headline image
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish ↗
Via Stocktwits
News headline image
US Judge Upholds FDA Decision To Remove Wegovy, Ozempic From Shortage List In Move Against Compounding Pharmacies ↗
Via Stocktwits
Topics Lawsuit
News headline image
Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking ↗
Via Stocktwits
News headline image
Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’ ↗
Via Stocktwits
News headline image
Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels ↗
Via Stocktwits
Topics Artificial Intelligence Economy
News headline image
WeRide Partners With Renault To Provide Autonomous Shuttle At The French Open, But Retail’s Not Excited ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Roche Gets Positive Opinion For Approval Of Cancer Therapy In EU: Retail Yet To React ↗
Via Stocktwits
Topics Government
News headline image
Novo Nordisk To Sell Wegovy For $199 A Month As Compounding Ban Nears: Retail’s Bullish ↗
Via Stocktwits
News headline image
WeRide Narrows Losses In Q1, Announces $100M Share Repurchase Program: Retail’s Thrilled ↗
Via Stocktwits
News headline image
Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes ↗
Via Stocktwits
News headline image
Tencent Revenue Tops Forecasts On Gaming Surge, AI Ad Gains As Stock Rallies ↗
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
Novo Nordisk Stock Rises Pre-Market On Q1 Beat Despite Lowering Outlook – Retail’s Elated ↗
Via Stocktwits
Topics Earnings Law Enforcement
News headline image
Novo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast Asia ↗
Via Stocktwits

Frequently Asked Questions

Is ActivePassive International Equity ETF publicly traded?
Yes, ActivePassive International Equity ETF is publicly traded.
What exchange does ActivePassive International Equity ETF trade on?
ActivePassive International Equity ETF trades on the New York Stock Exchange
What is the ticker symbol for ActivePassive International Equity ETF?
The ticker symbol for ActivePassive International Equity ETF is APIE on the New York Stock Exchange
What is the current price of ActivePassive International Equity ETF?
The current price of ActivePassive International Equity ETF is 37.13
When was ActivePassive International Equity ETF last traded?
The last trade of ActivePassive International Equity ETF was at 04/08/26 08:00 PM ET
What is the market capitalization of ActivePassive International Equity ETF?
The market capitalization of ActivePassive International Equity ETF is 9.57M
How many shares of ActivePassive International Equity ETF are outstanding?
ActivePassive International Equity ETF has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story